2026 Global: Apheresis Equipment Market-Competitive Review (2032) report
Description
The 2026 Global: Apheresis Equipment Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for apheresis equipment market by geography and historical trend. The scope of the report extends to sizing of the apheresis equipment market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Terumo BCT leads the apheresis equipment market with a broad portfolio including the Spectra Optia system for therapeutic apheresis and cell collections, strong global distribution in hospitals and blood centers, and sustained R&D investment to support cell therapy and transfusion applications. Haemonetics offers comprehensive apheresis solutions focused on donor and therapeutic procedures, emphasizing device automation, safety features, and service networks that support blood banks and hospital clients worldwide. Fresenius (through Fresenius Kabi and Fresenius Medical Care) competes across donor apheresis and therapeutic segments by leveraging its scale in dialysis and hospital services, enabling cross-selling of consumables and expanding into emerging markets via clinic and product networks. B. Braun supplies a range of apheresis consumables and systems as part of a diversified product offering, using its large manufacturing base and global footprint to support adoption in clinical and blood center settings. Baxter contributes with product lines and disposables for plasma and cell processing that target both established transfusion services and growing cell-therapy workflows, backed by its global commercial and regulatory capabilities.
Asahi Kasei and Kaneka are prominent Japanese players offering membrane and filtration technologies, disposables, and integrated systems that serve plasmapheresis and specialized therapeutic applications, with Asahi Kasei also extending bioprocessing and filter technologies into pharmaceutical and clinical markets. Nikkiso and Kawasumi (SB-Kawasumi Laboratories) provide regionally strong apheresis platforms and consumables—Nikkiso expanding its blood purification and apheresis product launches in Europe and Asia and Kawasumi focusing on dedicated apheresis devices and tubing sets for clinical use. Medica S.p.A. and Macopharma supply specialized apheresis systems, disposables and services to European blood banks and hospital networks, emphasizing customization and local support to maintain competitiveness among consolidated global suppliers. Cerus and other niche firms (including Miltenyi Biotec and Macopharma for cell processing niches) bolster the market with pathogen-reduction technologies, cell processing tools and therapy-focused consumables that align with the rising demand for cellular therapies and safer blood products.
Market dynamics concentrate leadership among these ten firms while opening opportunities for adjacent entrants and specialized suppliers: consolidation through M&A and partnerships strengthens end‑to‑end offerings, while investment in automation, single‑use consumables and cell‑therapy compatible platforms differentiates competitors and addresses clinician demand for efficiency and safety. Geographic expansion—particularly into Asia Pacific and Latin America—remains a strategic priority, with manufacturers building distribution, training and service capacity to capture rising apheresis volumes and the growing use of therapeutic apheresis and collection for cell therapies. Regulatory approvals, reimbursement environments and collaborations with blood centers, hospitals and biotech companies will continue to shape competitive positioning as demand for advanced apheresis devices and consumables increases globally.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for apheresis equipment market by geography and historical trend. The scope of the report extends to sizing of the apheresis equipment market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Terumo BCT leads the apheresis equipment market with a broad portfolio including the Spectra Optia system for therapeutic apheresis and cell collections, strong global distribution in hospitals and blood centers, and sustained R&D investment to support cell therapy and transfusion applications. Haemonetics offers comprehensive apheresis solutions focused on donor and therapeutic procedures, emphasizing device automation, safety features, and service networks that support blood banks and hospital clients worldwide. Fresenius (through Fresenius Kabi and Fresenius Medical Care) competes across donor apheresis and therapeutic segments by leveraging its scale in dialysis and hospital services, enabling cross-selling of consumables and expanding into emerging markets via clinic and product networks. B. Braun supplies a range of apheresis consumables and systems as part of a diversified product offering, using its large manufacturing base and global footprint to support adoption in clinical and blood center settings. Baxter contributes with product lines and disposables for plasma and cell processing that target both established transfusion services and growing cell-therapy workflows, backed by its global commercial and regulatory capabilities.
Asahi Kasei and Kaneka are prominent Japanese players offering membrane and filtration technologies, disposables, and integrated systems that serve plasmapheresis and specialized therapeutic applications, with Asahi Kasei also extending bioprocessing and filter technologies into pharmaceutical and clinical markets. Nikkiso and Kawasumi (SB-Kawasumi Laboratories) provide regionally strong apheresis platforms and consumables—Nikkiso expanding its blood purification and apheresis product launches in Europe and Asia and Kawasumi focusing on dedicated apheresis devices and tubing sets for clinical use. Medica S.p.A. and Macopharma supply specialized apheresis systems, disposables and services to European blood banks and hospital networks, emphasizing customization and local support to maintain competitiveness among consolidated global suppliers. Cerus and other niche firms (including Miltenyi Biotec and Macopharma for cell processing niches) bolster the market with pathogen-reduction technologies, cell processing tools and therapy-focused consumables that align with the rising demand for cellular therapies and safer blood products.
Market dynamics concentrate leadership among these ten firms while opening opportunities for adjacent entrants and specialized suppliers: consolidation through M&A and partnerships strengthens end‑to‑end offerings, while investment in automation, single‑use consumables and cell‑therapy compatible platforms differentiates competitors and addresses clinician demand for efficiency and safety. Geographic expansion—particularly into Asia Pacific and Latin America—remains a strategic priority, with manufacturers building distribution, training and service capacity to capture rising apheresis volumes and the growing use of therapeutic apheresis and collection for cell therapies. Regulatory approvals, reimbursement environments and collaborations with blood centers, hospitals and biotech companies will continue to shape competitive positioning as demand for advanced apheresis devices and consumables increases globally.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
